Cargando…

Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic

BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal...

Descripción completa

Detalles Bibliográficos
Autores principales: Clissold, Rhian L, Fulford, Jon, Hudson, Michelle, Shields, Beverley M, McDonald, Timothy J, Ellard, Sian, Hattersley, Andrew T, Bingham, Coralie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070112/
https://www.ncbi.nlm.nih.gov/pubmed/30094008
http://dx.doi.org/10.1093/ckj/sfx150
_version_ 1783343622747324416
author Clissold, Rhian L
Fulford, Jon
Hudson, Michelle
Shields, Beverley M
McDonald, Timothy J
Ellard, Sian
Hattersley, Andrew T
Bingham, Coralie
author_facet Clissold, Rhian L
Fulford, Jon
Hudson, Michelle
Shields, Beverley M
McDonald, Timothy J
Ellard, Sian
Hattersley, Andrew T
Bingham, Coralie
author_sort Clissold, Rhian L
collection PubMed
description BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal elastase-1 in patients with HNF1B-associated disease regardless of diabetes status and assessed the degree of symptoms associated with pancreatic exocrine deficiency. METHODS: Faecal elastase-1 was measured in 29 patients with a known HNF1B mutation. We defined a low faecal elastase-1 concentration based on the 2.5 percentile of 99 healthy control individuals (410 μg/g stool). Symptoms related to pancreatic exocrine dysfunction were assessed and a subset of the HNF1B cohort (n  =  6) underwent pancreatic imaging. RESULTS: Faecal elastase-1 was below the 2.5 percentile of the control cohort in 18/29 (62%) patients with HNF1B-associated renal disease. A total of 8/29 (28%) had a measurement suggestive of exocrine pancreatic insufficiency at  <200 μg/g stool; of these, 3 suffered with abdominal pain, loose stools and/or unintentional weight loss. All three experienced symptomatic improvement and weight gain after commencing pancreatic enzyme replacement therapy. Faecal elastase-1 was low in 7/15 (47%) HNF1B patients without diabetes compared with 11/14 (79%) of those with diabetes (P  =  0.1). CONCLUSIONS: Faecal elastase-1 deficiency is a common feature of HNF1B-associated renal disease even when diabetes is not present and pancreatic exocrine deficiency may be more symptomatic than previously suggested. Faecal elastase-1 should be measured in all patients with known HNF1B-associated disease complaining of chronic abdominal pain, loose stools or unintentional weight loss. The discovery of a low faecal elastase-1 concentration in individuals with developmental kidney disease of uncertain cause should prompt referral for HNF1B genetic testing.
format Online
Article
Text
id pubmed-6070112
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-60701122018-08-09 Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic Clissold, Rhian L Fulford, Jon Hudson, Michelle Shields, Beverley M McDonald, Timothy J Ellard, Sian Hattersley, Andrew T Bingham, Coralie Clin Kidney J Genetic Kidney Diseases BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal elastase-1 in patients with HNF1B-associated disease regardless of diabetes status and assessed the degree of symptoms associated with pancreatic exocrine deficiency. METHODS: Faecal elastase-1 was measured in 29 patients with a known HNF1B mutation. We defined a low faecal elastase-1 concentration based on the 2.5 percentile of 99 healthy control individuals (410 μg/g stool). Symptoms related to pancreatic exocrine dysfunction were assessed and a subset of the HNF1B cohort (n  =  6) underwent pancreatic imaging. RESULTS: Faecal elastase-1 was below the 2.5 percentile of the control cohort in 18/29 (62%) patients with HNF1B-associated renal disease. A total of 8/29 (28%) had a measurement suggestive of exocrine pancreatic insufficiency at  <200 μg/g stool; of these, 3 suffered with abdominal pain, loose stools and/or unintentional weight loss. All three experienced symptomatic improvement and weight gain after commencing pancreatic enzyme replacement therapy. Faecal elastase-1 was low in 7/15 (47%) HNF1B patients without diabetes compared with 11/14 (79%) of those with diabetes (P  =  0.1). CONCLUSIONS: Faecal elastase-1 deficiency is a common feature of HNF1B-associated renal disease even when diabetes is not present and pancreatic exocrine deficiency may be more symptomatic than previously suggested. Faecal elastase-1 should be measured in all patients with known HNF1B-associated disease complaining of chronic abdominal pain, loose stools or unintentional weight loss. The discovery of a low faecal elastase-1 concentration in individuals with developmental kidney disease of uncertain cause should prompt referral for HNF1B genetic testing. Oxford University Press 2018-08 2018-01-30 /pmc/articles/PMC6070112/ /pubmed/30094008 http://dx.doi.org/10.1093/ckj/sfx150 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Genetic Kidney Diseases
Clissold, Rhian L
Fulford, Jon
Hudson, Michelle
Shields, Beverley M
McDonald, Timothy J
Ellard, Sian
Hattersley, Andrew T
Bingham, Coralie
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title_full Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title_fullStr Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title_full_unstemmed Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title_short Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
title_sort exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
topic Genetic Kidney Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070112/
https://www.ncbi.nlm.nih.gov/pubmed/30094008
http://dx.doi.org/10.1093/ckj/sfx150
work_keys_str_mv AT clissoldrhianl exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT fulfordjon exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT hudsonmichelle exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT shieldsbeverleym exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT mcdonaldtimothyj exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT ellardsian exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT hattersleyandrewt exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic
AT binghamcoralie exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic